Work

Phase II Trial of Subcutaneous Interleukin-2, Subcutaneous Interferon- α , 5-Fluorouracil and Cis-retinoic Acid in the Treatment of Renal Cell Carcinoma: Final Results of Cancer Biotherapy Research Group 94-10

Year: 2002

Type: article

Study design: Clinical Trial

Source: Cancer Biotherapy and Radiopharmaceuticals

DOI: 10.1089/108497802753773784

Authors: Gamini Soori, Robert O. Dillman, Michael C. Wiemann, James J. Stark, Fritz Tai, Carol B. DePriest, Curtis K. Church, Richard Schulof

Institutions: CHI Health Creighton University Medical Center - Bergan Mercy, Hoag Memorial Hospital Presbyterian, St Vincent Hospital, Cancer Treatment Centers of America, Middle Tennessee State University

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2004048702

FWCI: 1.103

Cites: 46

Cited by: 13

Related to: 10